Faron Pharmaceuticals Oy (FARN.L)
GBp 175.0
(2.94%)
GBp 175.0
(2.94%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 13.11 Million EUR | -1.19% |
| 2022 | 13.26 Million EUR | 274.09% |
| 2021 | 3.54 Million EUR | 9.98% |
| 2020 | 3.22 Million EUR | 14.28% |
| 2019 | 2.82 Million EUR | 32.36% |
| 2018 | 2.13 Million EUR | -12.12% |
| 2017 | 2.42 Million EUR | 14.11% |
| 2016 | 2.12 Million EUR | -0.05% |
| 2015 | 2.12 Million EUR | 25.78% |
| 2014 | 1.69 Million EUR | -16.82% |
| 2013 | 2.03 Million EUR | -21.75% |
| 2012 | 2.59 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 12.37 Million EUR | -5.59% |
| 2024 Q2 | 12.37 Million EUR | 2.78% |
| 2023 Q2 | 13.47 Million EUR | 0.89% |
| 2023 Q1 | 13.35 Million EUR | 0.68% |
| 2023 Q3 | 12.94 Million EUR | -3.93% |
| 2023 Q4 | 13.11 Million EUR | 1.26% |
| 2023 FY | 13.11 Million EUR | -1.19% |
| 2022 Q1 | 12.25 Million EUR | 245.36% |
| 2022 Q3 | 13.11 Million EUR | 6.15% |
| 2022 FY | 13.26 Million EUR | 274.09% |
| 2022 Q4 | 13.26 Million EUR | 1.17% |
| 2022 Q2 | 12.35 Million EUR | 0.87% |
| 2021 Q3 | 3.36 Million EUR | -4.41% |
| 2021 Q2 | 3.51 Million EUR | 5.33% |
| 2021 Q1 | 3.34 Million EUR | 3.57% |
| 2021 FY | 3.54 Million EUR | 9.98% |
| 2021 Q4 | 3.54 Million EUR | 5.47% |
| 2020 Q3 | 3.04 Million EUR | 9.99% |
| 2020 FY | 3.22 Million EUR | 14.28% |
| 2020 Q4 | 3.22 Million EUR | 5.77% |
| 2020 Q2 | 2.77 Million EUR | 6.99% |
| 2020 Q1 | 2.59 Million EUR | -8.19% |
| 2019 Q4 | 2.82 Million EUR | 5.02% |
| 2019 FY | 2.82 Million EUR | 32.36% |
| 2019 Q1 | 2.36 Million EUR | 10.83% |
| 2019 Q2 | 2.36 Million EUR | 0.0% |
| 2019 Q3 | 2.68 Million EUR | 13.71% |
| 2018 FY | 2.13 Million EUR | -12.12% |
| 2018 Q3 | 2.13 Million EUR | 1.28% |
| 2018 Q1 | 2.1 Million EUR | -13.23% |
| 2018 Q2 | 2.1 Million EUR | 0.0% |
| 2018 Q4 | 2.13 Million EUR | 0.0% |
| 2017 Q1 | 2.49 Million EUR | 17.54% |
| 2017 Q4 | 2.42 Million EUR | 0.0% |
| 2017 Q3 | 2.42 Million EUR | -46.21% |
| 2017 Q2 | 4.51 Million EUR | 80.47% |
| 2017 FY | 2.42 Million EUR | 14.11% |
| 2016 Q3 | 2.17 Million EUR | -31.12% |
| 2016 FY | 2.12 Million EUR | -0.05% |
| 2016 Q1 | 2.15 Million EUR | 1.08% |
| 2016 Q2 | 3.15 Million EUR | 46.93% |
| 2016 Q4 | 2.12 Million EUR | -2.3% |
| 2015 Q2 | 1.69 Million EUR | 0.0% |
| 2015 Q4 | 2.12 Million EUR | 25.78% |
| 2015 Q3 | 1.69 Million EUR | 0.0% |
| 2015 Q1 | 1.69 Million EUR | 0.0% |
| 2015 FY | 2.12 Million EUR | 25.78% |
| 2014 FY | 1.69 Million EUR | -16.82% |
| 2014 Q1 | - EUR | 0.0% |
| 2014 Q3 | 1.69 Million EUR | 0.0% |
| 2014 Q4 | 1.69 Million EUR | 0.0% |
| 2013 FY | 2.03 Million EUR | -21.75% |
| 2012 FY | 2.59 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|